Key terms

About TTOO

T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TTOO news

May 07 7:51am ET T2 Biosystems: Hold Rating Maintained Amid Growth Prospects and Profitability Concerns May 06 4:57pm ET T2 Biosystems announces distribution agreement in Qatar Apr 29 6:58am ET T2 Biosystems price target lowered to $3 from $12 at Canaccord Apr 22 5:15pm ET T2 Biosystems files to sell common stock and warrants, no amount given Apr 11 4:08pm ET T2 Biosystems shareholders vote for CRG debt conversion into equity Mar 28 4:53pm ET T2 Biosystems Reinforces Market Position with Extended Vizient Agreement Mar 28 9:08am ET T2 Biosystems announces extension of multi-year agreement with Vizient Mar 20 9:32am ET T2 Biosystems Anticipates Breakthroughs and Extends NASDAQ Compliance Mar 20 9:23am ET T2 Biosystems reiterates 2024 financial outlook Mar 20 7:37am ET T2 Biosystems unveils T2Lyme launch plans, business updates Mar 18 9:23am ET T2 Biosystems Revolutionizes Infection Detection Efficiency Mar 18 9:02am ET T2 Biosystems announces new publication on T2Resistance Panel Mar 12 9:11am ET T2 Biosystems receives extension to comply with Nasdaq listing requirement Feb 15 5:07pm ET T2 Biosystems’ Strong Financials and Strategic Growth Moves Feb 15 4:38pm ET T2 Biosystems announces new territory exclusive distribution agreements Feb 12 9:03am ET T2 Biosystems receives FDA clearance for expanded T2Bacteria panel

TTOO Financials

1-year income & revenue

Key terms

TTOO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TTOO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms